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PERSPECTIVE
Rho deep in thought
Rachel McMullan and Stephen J. Nurrish1
Medical Research Council (MRC) Cell Biology Unit, MRC Laboratory for Molecular Cell Biology and Department of
Pharmacology, University College, London WC1E 6BT, United Kingdom
Neuronal communication underlies all aspects of brain
function, including learning, memory, and conscious-
ness. How neurons communicate is controlled by both
the formation of neuronal connections during neural de-
velopment and the regulation of neuronal activity in the
adult brain. Rho GTPases have a well-known role in neu-
ronal development, and recent studies published in
Genes & Development (Steven et al. 2005; McMullan et
al. 2006) have demonstrated that they also regulate neu-
ronal activity in the adult brain—at least in Caenorhab-
ditis elegans. Rho in C. elegans acts as part of a network
of Gq pathways that increase neuronal activity by regu-
lating both production and destruction of the second
messenger diacylglycerol (DAG), which is a regulator of
synaptic vesicle release. In this issue of Genes & Devel-
opment, Williams et al. (2007) demonstrate that Gq acts
via the UNC-73RhoGEF to increase Rho activity in neu-
rons, and thus increase levels of DAG. The targets of
DAG are known and, in one case, a pathway stretching
from binding of ligand on the cell surface to changes in
synaptic vesicle priming has been mapped out.
Go and Gq antagonistically control neuronal activity
C. elegans has proven to be an excellent model to study
how changes in neuronal activity regulate behavior. Cur-
rently, the C. elegans cholinergic motorneuron repre-
sents the best-understood example of multiple G-protein
signaling pathways acting within a single neuron to
regulate neuronal activity. C.elegans has 21 G sub-
units. These include one ortholog of each mammalian
G family: GOA-1 (Gi/o), EGL-30 (Gq), GSA-1 (Gs),
and GPA-12 (G12). The remainder are most closely re-
lated to Gi/o, but are specific to C. elegans. All four of the
G orthologs modulate neuronal activity—most com-
monly, locomotion and acetylcholine (ACh) release. The
first two G proteins identified as regulators of C. elegans
neuronal activity were Go/i (GOA-1, henceforth re-
ferred to as Go) and Gq (EGL-30).
Go (goa-1) was the first G-protein  subunit shown to
regulate C. elegans behavior (Mendel et al. 1995; Segalat
et al. 1995). Go mutants have increased locomotion, egg
laying, and ACh release, and are resistant to some effects
of serotonin on behavior. The increased locomotion of
Go mutant animals is referred to as the hyper pheno-
type. Expression of constitutively active Go in the cho-
linergic motorneurons decreases locomotion and ACh
release. Loss of Go specifically in the cholinergic mo-
torneurons causes the same increases in locomotion and
ACh release as caused by a complete loss of Go in all
cells (Nurrish et al. 1999). Thus, Go acts within the
cholinergic motorneurons to decrease neuronal activity,
which we shall define as rate of locomotion and/or rate
of ACh release.
Gq (egl-30) mutations have decreased locomotion,
egg laying, and ACh release, and are resistant to the le-
thal effects of the muscarinic agonist arecoline or the
acetylcholinesterase inhibitor aldicarb (Trent et al. 1983;
Brundage et al. 1996; Miller et al. 1996, 1999; Hajdu-
Cronin et al. 1999; Lackner et al. 1999). The decreased
locomotion of Gq mutant animals is referred to as the
lethargic phenotype. Expression of activated Gq in the
cholinergic motorneurons increases both locomotion
rate and ACh release (Lackner et al. 1999), which is the
opposite effect of Go. This suggests that Gq and Go
act antagonistically in cholinergic motorneurons to con-
trol neuronal activity: Gq increases neuronal activity,
whereas Go decreases neuronal activity (Fig. 1).
Go and Gq antagonistically regulate levels of DAG
The key to understanding how Go and Gq antagonis-
tically regulate neuronal activity came with the cloning
of DGK-1 (Nurrish et al. 1999). Both Go and dgk-1 mu-
tants were identified in the screen for resistance to sero-
tonin inhibition of locomotion. dgk-1 mutants were also
identified as suppressors of a constitutively active Go
(Hajdu-Cronin et al. 1999; Nurrish et al. 1999). Both Go
and dgk-1 mutants have increased locomotion and ACh
release. DGK-1 encodes a DAG kinase, which phos-
phorylates the membrane-bound second messenger
DAG, converting it to another membrane-bound second
messenger, Phosphatidic acid (PA). dgk-1 mutants are
predicted to have elevated levels of DAG and lowered
levels of PA. Addition of the DAG analog PMA (a phor-
bol ester) causes wild-type animals to have the same phe-
notype as dgk-1 mutants (Lackner et al. 1999; Miller et
al. 1999; Nurrish et al. 1999), which suggests that the
hyperactive locomotion and egg laying of dgk-1 animals
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results from an excess of DAG. Go mutants, which
closely resemble dgk-1 mutants, also have increased lev-
els of DAG, specifically at neurotransmitter release sites
(Nurrish et al. 1999). A role for DAG is further supported
by the cloning of PLC egl-8. PLC egl-8 mutants have
decreased locomotion, ACh release, and egg laying,
which is similar to Gq mutants (Trent et al. 1983; Lack-
ner et al. 1999; Miller et al. 1999). EGL-8 is a PLC that,
when activated by Gq, hydrolyzes Phosphatidylinositol
(4,5)-bisphosphate (PIP2) into DAG and IP3; hence, PLC
egl-8 mutants are predicted to have decreased levels of
DAG. The lethargic locomotion and egg-laying pheno-
types of both Gq and PLC egl-8 mutants are com-
pletely suppressed by addition of PMA. Thus, mutants
with increased levels of DAG (Go and dgk-1) are hyper,
whereas mutants with decreased levels of DAG (Gq and
PLC egl-8) are lethargic. These data suggest a model in
which Gq and Gq act within the cholinergic motor-
neurons to antagonistically control levels of the second
messenger DAG. Increases in DAG stimulate locomo-
tion and ACh release (Fig. 1).
How is it that DAG regulates ACh release? A series of
studies by the Kaplan laboratory (Lackner et al. 1999;
Nurrish et al. 1999; Sieburth et al. 2006) demonstrated
that both UNC-13 and PKC-1 are required for DAG-me-
diated increases in cholinergic motorneuron activity. In
mammals, UNC-13 and PKC homologs are also required
for DAG-mediated increases in neuronal activity. In
mammalian neurons, UNC-13 and PKC act together
such that mutations in one fully block the effects of
PMA (Rhee et al. 2002; Wierda et al. 2007). However, in
C. elegans UNC-13 and PKC-1 act in parallel such that a
mutation in both is required to completely block PMA
stimulation of neuronal activity. It is possible that dif-
ferent neurons of both the C. elegans and mammalian
brain have differences in the integration of UNC-13 and
PKC-1 signaling; alternatively, DAG effectors may be
used differently in mammalian and C. elegans neurons
to regulate neuronal activity.
UNC-13 binds to and positively regulates one of the C.
elegans syntaxins, UNC-64, to promote synaptic vesicle
docking and priming (although UNC-13 is likely to have
other effectors as well) (Richmond et al. 2001; Madison
et al. 2005; McEwen et al. 2006; Hammarlund et al.
2007). Thus, a pathway has been established stretching
from the receiving of extracellular signals (activation of
Gq-coupled receptors by arecoline) all the way to the
core synaptic release machinery (Fig. 1).
RHO-1 regulates neuronal activity
C. elegans Rho GTPases include one Rho (RHO-1), one
Cdc42 (CDC-42), two Rac (RAC-1, RAC-2), and one in-
termediate by homology between Cdc42 and Rac (MIG-
2). Evidence that RHO-1 is involved with regulation of
neuronal activity first came from mutation of the Rho-
GEF domain of unc-73 (Steven et al. 2005). UNC-73 is an
ortholog of mammalian Trio. These proteins contain
separate RacGEF and RhoGEF domains that activate Rac
and Rho GTPases, respectively. Both GEF domains can
be present in the same protein or in separate proteins as
a result of alternative splicing. Mutations in the UNC-
73RacGEF domain result in defective axon guidance
(Steven et al. 1998). Steven et al. (2005) isolated a dele-
tion in the UNC-73RhoGEF domain that still allows
expression of proteins carrying a functional UNC-
73RacGEF domain. Loss of UNC-73RhoGEF in the ner-
vous system causes reduced locomotion and egg laying;
the egg-laying defect is so severe that eggs hatch within
the parent, resulting in the “bag of worms” phenotype.
UNC-73RhoGEF mutations are very similar to severe
loss-of-function Gq mutations; however, unlike Gq
mutations, the UNC-73RhoGEF mutation causes only a
small defect in ACh release. Nontheless, these data dem-
onstrate for the first time that a RhoGEF, and thus RHO-1,
stimulates neuronal activity in C. elegans.
At the same time, the Nurrish laboratory (McMullan
et al. 2006) set out to test whether neuronal activity is
regulated by control of DAG removal. DAG is removed
by DAG kinases, which include DGK-1. The human or-
tholog of DGK-1, DGK, binds to and is inactivated by
RhoA (Houssa et al. 1999). This interaction is conserved
in C. elegans. Expression of constitutively active RHO-1
in the cholinergic motorneurons increases locomotion
and ACh release. Thus, increased RHO-1 signaling mim-
ics addition of PMA or a mutation in dgk-1. In contrast,
inhibition of endogenous RHO-1 in the cholinergic mo-
torneurons decreases locomotion and ACh release. As
with Go and dgk-1 mutants, activated RHO-1 increases
levels of DAG. These results are consistent with a model
where RHO-1 inhibits DGK-1 activity in the cholinergic
Figure 1. Multiple G proteins control the production and de-
struction of DAG to regulate neuronal activity. A model for
G-protein networks acting within C. elegans cholinergic mo-
torneurons to regulate neuronal activity. Shown in blue are
those proteins that increase neuronal activity (as defined by
increases in locomotion and/or ACh release), whereas those in
red decrease neuronal activity. In green are downstream effec-
tors of DAG. DAG is formed by the hydrolysis of PIP2, and
DAG is removed by phosphorylation to form PA. C. elegans
protein names are shown with mammalian orthologs in brack-
ets. Not shown is Gs, whose role in control of cholinergic
motorneuron activity remains unclear.
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motorneurons; this results in a rise of DAG and, thus, an
increase in neuronal activity (Fig. 1).
Completing the integration of RHO-1 into G-protein
control of neuronal activity, Williams et al. (2007) iden-
tified RHO-1 as a downstream effector of Gq (Fig. 1).
Although the PLC EGL-8 acts downstream from Gq, it
is clear that PLC EGL-8 is not the only Gq effector.
Gq mutants grow very slowly and null mutants are
barely alive, whereas null PLC egl-8 mutants are
healthy and grow normally. Also, expression of activated
Gq in the cholinergic motorneurons increases both lo-
comotion and ACh release, and these effects are only
partially suppressed by PLC egl-8 mutants (Lackner et
al. 1999; Miller et al. 1999). Screens for the missing Gq
effector identify mutations in unc-73 specific for the
UNC-73RhoGEF transcripts. PLC egl-8;unc-73RhoGEF
double mutants closely resemble the Gq-null mutants.
Both are almost completely paralyzed and grow very
poorly, suggesting that Gq signals through both PLC
EGL-8 and UNC-73RhoGEF. However, only PLC egl-8
mutants have a strong reduction in ACh release, and
only unc-73RhoGEF mutants have the severe “bag of
worms” egg-laying defect, both of which are observed in
Gq mutants. Thus, Gq signals more strongly through
PLC EGL-8 to regulate ACh release. In contrast, Gq
signals more strongly through UNC-73RhoGEF to regu-
late egg laying. The differing effects of these two Gq
effector pathways may reflect differences in the down-
stream targets of PLC EGL-8 and UNC-73RhoGEF. For
example, PLC produces IP3, which acts to increase in-
tracellular Ca2+, whereas RHO-1 signaling is likely to
alter actin dynamics.
Multiple RhoGEFs regulate neuronal activity
UNC-73RhoGEF belongs to a new class of RhoGEFs
regulated by G proteins (Lutz et al. 2005, 2007; Rojas et
al. 2007). The study by Williams et al. (2007) represents
the first in vivo evidence that this class of RhoGEFs is
important for Gq signaling. Another class of RhoGEFs
that are regulated by G-proteins are those containing a
Regulator of G-protein Signaling (RGS) domain. C. el-
egans has a single RGS-containing RhoGEF, RHGF-1,
which is homologous to mammalian p115 RGSRhoGEF
and is regulated by G12. In C. elegans, expression of
activated G12 in the cholinergic motorneurons in-
creases levels of ACh release in a RHGF-1- and RHO-1-
dependent manner. (Hiley et al. 2006). However, null
mutations in both G12 and RHGF-1 have no effect on
ACh release under standard laboratory conditions. Thus,
it is unclear under what conditions G12 signaling to
RHO-1 is active.
Both UNC-73 and RHGF-1 RhoGEFs can stimulate
RHO-1 to increase neuronal activity, but are these the
only RhoGEFs active in the adult nervous system? Inhi-
bition of endogenous RHO-1 within the cholinergic mo-
torneurons causes a strong reduction in both locomotion
and ACh release. This suggests that a RhoGEF must ac-
tivate RHO-1 in the cholinergic motorneurons. How-
ever, mutations in either UNC-73RhoGEF or RHGF-1
have a very small decrease of ACh release. Perhaps these
two RhoGEFs act redundantly within the cholinergic
motorneurons? Alternatively, there are 21 Dbl Homol-
ogy domain-containing RhoGEFs in C. elegans; perhaps
other RhoGEFs also regulate neuronal activity? Analysis
of an unc-73RhoGEF;rhgf-1 double mutant will answer
this question.
Does Gq signal via PLC EGL-8 and UNC-73RhoGEF
in the same cells?
An important question is whether or not Gq signals
through PLC EGL-8 and UNC-73RhoGEF in the same
cells. Several site-of-action experiments have been per-
formed on many of the proteins discussed so far. Trans-
genes expressing activated versions of Gq, Go, and
RHO-1 in the cholinergic motorneurons alter both loco-
motion and ACh release (Lackner et al. 1999; Nurrish et
al. 1999; McMullan et al. 2006). Inactivation of endog-
enous Go or RHO-1 in the cholinergic motorneurons is
sufficient to alter both locomotion and ACh release
(Nurrish et al. 1999; McMullan et al. 2006). Cholinergic
motorneuron-specific expression of PLC EGL-8 or
DGK-1 in egl-8 or dgk-1 mutants, respectively, is suffi-
cient to rescue their locomotion and ACh release defects
(Lackner et al. 1999; Nurrish et al. 1999). Thus, Gq,
Go, PLC EGL-8, DGK-1, and RHO-1 all act within the
cholinergic motorneurons to regulate locomotion and
ACh release. However, Gq, Go, and RHO-1 may also
be required in additional neurons for wild-type levels
of locomotion and ACh release. Expression of UNC-
73RhoGEF only in the cholinergic motorneurons fails to
rescue the decreased locomotion of unc-73RhoGEF mu-
tants, although UNC-73RhoGEF expression from a pan-
neural promoter does rescue locomotion (Steven et al.
2005; Williams et al. 2007). Thus, for wild-type locomo-
tion, UNC-73RhoGEF is required either in neuronal
cells other than the cholinergic motorneurons, or in both
the cholinergic motorneurons and another neuronal cell
type. Cholinergic motorneuron expression of activated
Gq causes an increase in locomotion and ACh release
that is only partially suppressed by a PLC egl-8 muta-
tion (Lackner et al. 1999). Therefore, UNC-73RhoGEF
must have a role in the cholinergic motorneurons, or a
third pathway downstream from Gq remains to be dis-
covered. It appears that all cells that express Gq also
express both PLC EGL-8 and UNC-73RhoGEF. Thus it
is unclear why in some neuronal cells UNC-73RhoGEF
is required but PLC EGL-8 is not. One possible expla-
nation is that, in some neurons, PLC EGL-8 acts redun-
dantly with another Gq-regulated PLC, possibly the
PLC-like PLC-2, although expression of PLC-2 has not
been observed in the nervous system.
There is still a lot we do not know about G-protein
regulation of neuronal activity
We still do not understand how Go regulates neuronal
activity. dgk-1 mutants suppress activated Go, but as
Rho deep in thought
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yet there is no evidence that Go regulates DGK-1. As
Gq;Go double mutants more closely resemble Gq
mutants, it has been suggested that Go acts upstream of
Gq. It is possible that Go targets other aspects of neu-
ronal function, such as ion channels. However, the ac-
cumulation of DAG at release sites in Go mutants
suggests that some aspect of DAG production or destruc-
tion must be regulated by Go (Nurrish et al. 1999).
Williams et al. (2007) isolated mutations in unc-108, a
RabGTPase, in the same Go mutant suppressor screen
that identified UNC-73RhoGEF mutations. Hopefully,
identification of Go mutant suppressors will uncover
the targets of Go signaling.
Another important question is: What are the down-
stream targets of RHO-1? DGK-1 and UNC-13 are im-
portant for RHO-1 regulation of ACh release, but they
only account for part of RHO-1’s effects; this suggests
that at least one additional pathway downstream from
RHO-1 must exist (McMullan et al. 2006). Perhaps
RHO-1 targets other components of the synaptic vesicle
cycle. Alternatively, changes in the actin cytoskeleton
may be required for efficient synaptic vesicle release.
We also do not know the downstream effector of PKC-
1. PKC-1 is required for the full response to DAG, and it
appears to stimulate neuropeptide release from the cho-
linergic motorneurons (Sieburth et al. 2006). Studies in
mammalian neurons suggest that a likely target of
PKC-1 is the neuromodulator UNC-18 (Wierda et al.
2007). However, attempts to block PKC-1 signaling in C.
elegans by mutating UNC-18 have failed so far (Sieburth
et al. 2006).
Gs activation in the nervous system increases both
locomotion and ACh release via activation of Protein
Kinase A (Schade et al. 2005). Both Gq and Gs muta-
tions strongly reduce locomotion, although Gs muta-
tions do not cause a defect in ACh release (Reynolds et
al. 2005). It is unclear where Gs acts, although cholin-
ergic motorneuron expression of an activated adenylate
cyclase, a Gs effector, rescues locomotion in mutants
defective for neuropeptide release (Charlie et al. 2006).
This suggests that Gs, like Gq, Go, and G12, does play
a role in the cholinergic motorneurons, and that all four
G proteins can act within the same cell to modulate
neuronal activity.
A model for the human brain?
G-protein signaling by both  and  subunits regulates
neuronal activity in the mammalian brain, although in
most cases this is linked to changes in ion channel func-
tion (Wettschureck and Offermanns 2005). Typically, in
mammalian neurons Gq signaling increases neuronal ac-
tivity, whereas Go/i signaling decreases it, as observed in
C. elegans. Knockouts of Go or Gq in mice do not alter
gross brain morphology but do cause severe neurological
defects, including hyperactive locomotion in the Go
knockout (Jiang et al. 1998). Rho is also important in the
human brain, as mutations in regulators and effectors of
Rho GTPases are associated with mental retardation in
humans (Govek et al. 2005). In mice, activation of Rho
GTPases improves learning and memory (Diana et al.
2007), while knockouts of Rho effectors impair it (Meng
et al. 2002, 2005; Soderling et al. 2003). Rac acts presyn-
aptically to regulate synaptic strength in Aplysia (Dous-
sau et al. 2000; Humeau et al. 2002), and both Rac and
Cdc42 induce exocytosis in mammalian secretory cells
(Kowluru et al. 1997; Brown et al. 1998). A role for Rho in
the regulation of mammalian neurotransmitter release is
less clear. In PC12 cells, RhoB is required for potentia-
tion of ACh release by lysophosphatidic acid (Ishida et al.
2004), and inhibition of Rho can inhibit potassium-
evoked release (Komuro et al. 1996). In contrast, adrena-
lin release from PC12 cells has been reported to be inde-
pendent of Rho (Wang et al. 2004) and, in some cases,
Rho signaling may even act to inhibit release by stabi-
lizing the actin cytoskeleton (Dillon and Goda 2005).
No conclusive links between Gq, Rho, and the syn-
aptic vesicle cycle have been made in the mammalian
brain. However, DAG is known to stimulate mamma-
lian neurotransmitter release, and C. elegans will serve
as an important model for understanding how DAG lev-
els are regulated in mammalian neurons.
The worm has a lot more to tell us
Studies in C. elegans show that DAG is a critical regu-
lator of neuronal activity, and that networks of G-pro-
tein signaling pathways exist to control both DAG pro-
duction and destruction (Fig. 1). Recent advances have
now placed Rho within those G-protein pathways that
control DAG destruction. Although we know a great
deal about how G proteins regulate neuronal activity,
there remain more components of these pathways to be
discovered. Future work is also likely to integrate other
types of pathways, such as receptor tyrosine kinases,
into a better understanding of how neuronal activity is
regulated. Particularly exciting is the recent use of ge-
nome-wide RNA interference screens to identify regula-
tors of neuronal activity (Sieburth et al. 2005). Finding
these pathways in C. elegans is likely to tell us a great
deal more about how communication in our own brains
is regulated.
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